Current openings at Appia Bio

Appia Bio is a preclinical stage biotech company founded in 2020 with the mission to bring innovative off-the-shelf cell therapies to patients with cancer and autoimmune diseases. Our novel platform can generate a broad array of allogeneic T cell types which can be further engineered to address challenges in tumor microenvironments. Our goal is to discover and develop allogeneic cell therapies across a broad array of disease indications with a scalability that increases access for patients.